Skip to main content

stock

AVBP · ArriVent BioPharma, Inc.

What ArriVent BioPharma, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live AVBP price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on AVBP.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
49,307,729 as of 2026-08-10 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-44.6%
ROA
-41.5%

Health

Current ratio
14.2x
Debt/equity
—

Deep value

NCAV
$366.30M
NCAV per share
$7.43
Price/NCAV
Locked
NNWC
$126.81M
NNWC per share
$2.57
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenue (not reported by this company)Gross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$52.69M-$49.89M
10-Q filed 2026-08-12
2026-03-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$46.11M-$43.32M
10-Q filed 2026-08-12
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$38.82M-$35.54M
10-K filed 2026-03-05
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$38.32M-$34.98M
10-Q filed 2025-11-10
2025-06-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$33.62M-$31.40M
10-Q filed 2026-08-12
2025-03-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$66.77M-$64.39M
10-Q filed 2026-08-12
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$23.70M-$20.63M
10-K filed 2026-03-05
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$24.23M-$20.56M
10-Q filed 2025-11-10
Assets
$394.72M
Equity
$366.84M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31—-$177.53M-$166.31M—
2024-12-31—-$94.31M-$80.49M—
2023-12-31—-$74.59M-$69.33M—

Company filings

1 offering filing in 12 months

events

  • Regulation FD disclosure, Other event

    Regulation FD disclosureOther event
    Oct 68-K
  • Material agreement, Results

    Material agreementResults
    Aug 128-K
  • Shareholder vote results

    Shareholder vote results
    Jun 228-K
  • Other event

    Other event
    May 118-K
  • Results

    Results
    May 118-K
  • Regulation FD disclosure, Other event

    Regulation FD disclosureOther event
    Mar 178-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

  • Point72

    Period Tue 30 Jun 2026

    0.0%Trimmed

All funds

News

Stories that named AVBP, and the market events around them.

Sign in to see this

Board

The AVBP board could not be loaded.

Retry the AVBP board

nakagai

Signals on AVBP come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the AVBP board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.